Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

Age and hypertension are associated with increased risks for cranial ischemic complications in GCA, while anticoagulant therapy may offer protective benefits.

The treatment has gained approval in the European Union (EU) for a range of conditions, including psoriatic arthritis, ...

A key regulatory win could turn this under-the-radar treatment into AbbVie's next billion-dollar success story.

Rohan Gauns Dessai, the secretary of the Goa Cricket Association (GCA), has been unanimously elected as the new joint ...

EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis: North Chicago, Illinois Monday, March 3, 2025, 15:00 Hrs [IST] AbbVie annou ...

Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia rheumatica — due to the steroid’s host ...

JAK inhibitor Rinvoq (upadacitinib) has been backed by the CHMP as a 15mg, once-daily treatment for adults with GCA, an ...

GCA and Union Grove will face off on Thursday, Feb. 27 at 7:30 p.m. ET. Don't miss out on any of the action with NFHS Network ...

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AbbVie's upadacitinib (Rinvoq) to treat adults with giant cell arteritis (GCA).